EUVIMEDEUVIMED entdecken
Crossref

Red wavelength-induced photobiomodulation enhances indocyanine green-based anticancer photodynamic therapy

Büşra Sirek, Nermin Topaloğlu

Medical Oncology · 19.11.2024 · 42 (1)

DOI: 10.1007/s12032-024-02558-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 19.11.2024. Verfasst von Büşra Sirek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Graduate School of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Turkey. Hauptthemen laut MEDLINE: Photochemotherapy, Indocyanine Green, Reactive Oxygen Species, Low-Level Light Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a global concern worldwide. Prostate cancer has high prevalence and mortality rates among men. Photodynamic therapy (PDT) is an alternative treatment that is promising and effective with fewer side-effects than conventional therapies. However, some factors may limit its efficacy. For this, PDT can be combined with other modalities such as photobiomodulation (PBM) which is commonly used for increased cell proliferation/differentiation and wound healing. In this study, PBM pre-treatment at 655 nm of wavelength with 1, 3, and 5 J/cm2 energy densities was applied to prostate cancer cells to investigate its role in indocyanine green (ICG)-mediated PDT applications. Following PBM treatment, various analyses were assessed including cell viability, cellular uptake of ICG, ATP production, nitric oxide release, reactive oxygen species generation, and the changes in mitochondrial membrane potential. Increased cell death was observed with the PBM pre-treatment at 1 and 3 J/cm2 energy densities depending on ICG incubation time. Intracellular ROS generation and nitric oxide release by PBM had a significant impact on anticancer PDT action. An enhanced anticancer PDT effect was obtained with the PBM pre-treatment which may become a valuable modality to increase the sensitivity of the cancerous cells to PDT applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyIndocyanine GreenReactive Oxygen SpeciesLow-Level Light TherapyProstatic NeoplasmsPhotosensitizing AgentsHumansMaleNitric OxideCell SurvivalCell Line, TumorMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

Indocyanine greenNitric oxidePhotobiomodulationPhotodynamic therapyProstate cancerReactive oxygen species

Substanzen

Indocyanine GreenReactive Oxygen SpeciesPhotosensitizing AgentsNitric Oxide

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Graduate School of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Turkey.
  • Department of Biomedical Engineering, Faculty of Engineering and Architecture, Izmir Katip Celebi University, Izmir, Turkey.
  • Department of Biomedical Engineering, Faculty of Engineering and Architecture, Izmir Katip Celebi University, Izmir, Turkey. nermin.topaloglu@ikcu.edu.tr.

Zitieren

APA

Sirek, B., & Topaloğlu, N. (2024). Red wavelength-induced photobiomodulation enhances indocyanine green-based anticancer photodynamic therapy. Medical Oncology, 42(1). https://doi.org/10.1007/s12032-024-02558-4

Vancouver

Sirek B, Topaloğlu N. Red wavelength-induced photobiomodulation enhances indocyanine green-based anticancer photodynamic therapy. Medical Oncology. 2024;42(1). doi:10.1007/s12032-024-02558-4

BibTeX
@article{Sirek2024,
  author = {Sirek, Büşra and Topaloğlu, Nermin},
  title = {Red wavelength-induced photobiomodulation enhances indocyanine green-based anticancer photodynamic therapy},
  journal = {Medical Oncology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s12032-024-02558-4}
}
Kostenlos starten →